Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
Single nucleotide polymorphisms (SNPs) in MYH9 and APOL1 on chromosome 22 (c22) are powerfully associated with non-diabetic end-stage renal disease (ESRD) in African Americans (AAs). Many AAs diagnosed with type 2 diabetic nephropathy (T2DN) have non-diabetic kidney disease, potentially masking dete...
Saved in:
| Main Authors: | Barry I Freedman, Carl D Langefeld, Lingyi Lu, Jasmin Divers, Mary E Comeau, Jeffrey B Kopp, Cheryl A Winkler, George W Nelson, Randall C Johnson, Nicholette D Palmer, Pamela J Hicks, Meredith A Bostrom, Jessica N Cooke, Caitrin W McDonough, Donald W Bowden |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-06-01
|
| Series: | PLoS Genetics |
| Online Access: | https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1002150&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epistatic role of the MYH9/APOL1 region on familial hematuria genes.
by: Konstantinos Voskarides, et al.
Published: (2013-01-01) -
Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.
by: Taras K Oleksyk, et al.
Published: (2010-07-01) -
Association between MYH9 and APOL1 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes in a Chinese Han Population
by: Hailing Zhao, et al.
Published: (2018-01-01) -
Direct Oral Anticoagulants in Patients With ESRD and Kidney Transplantation
by: Nicholas W. Lange, et al.
Published: (2025-01-01) -
Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease
by: Brandon Zimmerman, et al.
Published: (2025-01-01)